Study Population
ONTARGET®: 25,620 patients enrolled from 40 countries
TRANSCEND®: 5,926 patients enrolled from 40 countries
Inclusion criteria
- ≥ 55 years of age
- At high risk of cardiovascular disease:
- coronary artery disease
- peripheral arterial occlusive disease
- stroke or recent transient ischaemic attack
- diabetes with end-organ damage
- Intolerant to ACE inhibitors (TRANSCEND® ONLY)
Exclusion criteria
- Overt heart failure
- Arterial hypertension (>160/100 mmHg)
- Diabetic patients with proteinuria (TRANSCEND® ONLY)
Calendar
Tools and Downloads
My Alerts
You will shortly be able to create your own personal alerts service bringing the latest ONTARGET® news and updates direct to your inbox. Watch this space for more information.